The Journal for Nurse Practitioners
Volume 8, Issue 1 , Pages 61-66, January 2012

Impact of HPV Vaccine Availability on Uptake

  • Stephanie L. Small, PhD

      Affiliations

    • Stephanie L. Small, MSN, PhD, is a women's health nurse practitioner and can be reached
    • ,
  • Divya A. Patel, PhD

      Affiliations

    • Divya A. Patel, PhD, is an assistant professor in the department of obstetrics, gynecology, and reproductive sciences at Yale University. In compliance with national ethical guidelines, the authors report no relationships with business or industry that would pose a conflict of interest.

Abstract 

Purpose

To evaluate the impact of human papillomavirus (HPV) vaccine availability on uptake among 19- to 26-year-old female patients of Planned Parenthood of Mid and South Michigan before and after the vaccine became available at the health centers.

Results

Availability of the HPV vaccine increased vaccine uptake from 11% before clinic availability to 16% after availability. Accessibility, including cost and provider recommendation, may have influenced uptake.

Implications

Improving availability of the HPV vaccine, while helpful, is not sufficient for a substantial increase in uptake. Issues of accessibility, including cost and provider recommendation, must also be addressed.

Keywords:  HPV , human papillomavirus , uptake , vaccine

 

 The findings and conclusions in this article are those of the authors and do not necessarily represent the views of Planned Parenthood Federation of America, Inc.

PII: S1555-4155(11)00332-1

doi:10.1016/j.nurpra.2011.06.005

The Journal for Nurse Practitioners
Volume 8, Issue 1 , Pages 61-66, January 2012

Article Tools